Innolign Biomedical Overview
- Year Founded
-
2013

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Innolign Biomedical General Information
Description
Owner and operator of a biotechnology company intended to assist in therapeutic tissue regeneration. The company's biotechnology services focus on utilizing its novel microfabrication technologies and expertise in tissue engineering to develop high throughput organ-on-chip assessment platforms, enabling the pharmaceutical industry to design novel biomaterials as products for promoting therapeutic tissue regeneration.
Contact Information
Website
www.innolign.comCorporate Office
- 3160 Chestnut Street
- Suite 200
- Philadelphia, PA 19104
- United States
Corporate Office
- 3160 Chestnut Street
- Suite 200
- Philadelphia, PA 19104
- United States
Innolign Biomedical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Out of Business | 12-Feb-2021 | Completed | Out of Business | |||
3. Accelerator/Incubator | Completed | Startup | ||||
2. Accelerator/Incubator | 01-Dec-2013 | Completed | Startup | |||
1. Grant | 01-Jan-2013 | $385K | Completed | Startup |
Innolign Biomedical FAQs
-
When was Innolign Biomedical founded?
Innolign Biomedical was founded in 2013.
-
Where is Innolign Biomedical headquartered?
Innolign Biomedical is headquartered in Philadelphia, PA.
-
What industry is Innolign Biomedical in?
Innolign Biomedical’s primary industry is Biotechnology.
-
Is Innolign Biomedical a private or public company?
Innolign Biomedical is a Private company.
-
What is Innolign Biomedical’s current revenue?
The current revenue for Innolign Biomedical is
.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »